US Stocks
/
Abeona Therapeutics Inc. Share Price

Abeona Therapeutics Inc. Share Price

NASDAQ: ABEO
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Abeona Therapeutics Inc. Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Abeona Therapeutics Inc. Share Price Chart

$0.00$0.00
L
Show Current Price
H

Abeona Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.10
Revenue (TTM)
$5.82B
Return On Equity (TTM)
-49.11%
Profit Margin
1223.02%
Debt to Equity
0.12
Quarterly Earnings Growth YoY
-291.28%

Abeona Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$5.42$8.72$11.38
Net Profit-$5.16-$20.46-$17.08-$20.19
Net Profit MarginN/A-377.49%-195.87%-177.42%
Income ChangeN/A-296.51%16.52%-18.21%

Abeona Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.41$3.50$0.00$5.82
Net Profit-$43.48-$54.19-$63.73$71.18
Net Profit Margin-3083.69%-1548.29%N/A1223.02%
Income ChangeN/A-24.63%-17.60%211.69%

About Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Abeona Therapeutics Inc. Historical Returns

MonthOpenCloseChange %

ABEO Share Price FAQs

What is Abeona Therapeutics Inc. share price today?

chevron-up
Abeona Therapeutics Inc. share price today is $0.00 as on October 29, 2026 at 4:05 pm IST.

What is the 52 week high and 52 week low of Abeona Therapeutics Inc. stock?

chevron-up
52 week high/low data for Abeona Therapeutics Inc. is currently unavailable.

What is ABEO's net income for the last quarter?

chevron-up
ABEO's net income for the last quarter is -20.19B USD.

Can I buy ABEO shares in India?

chevron-up
Yes. You can buy ABEO in India by opening an international trading account.